I just want to note, Chair, that I think what was made very clear in testimony is the need for a so-called off-ramp so that the effectiveness of the list in general isn't diminished by substances being able to languish there even when new evidence is brought forward.
Certainly, although we would have liked to see it pass in its original form, acknowledging that creating a framework for an off-ramp is still important. Even with the subamendments, which change the original amendment somewhat, it still moves it in a direction that I think stakeholders certainly asked us to go.